About TNMI
TNMI is a Healthcare company based in Clarksville (United States) founded in 2001, and was acquired by Mundomedis in December 2021. Medical devices are developed and manufactured for surgical procedures. Its chief executive, as recorded, is Kai W Trompeter. TNMI offers products and services including Insightra Ultra 7FR IAB Catheter Kit and SmartVision Arthroscopy Pump. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is TNMI INC. Its competitors include InterValve, Insightra and Hybernia Medical; 3 of its 3 listed competitors have raised funding.
Company details
TNMI was founded in 2001 and is headquartered in Clarksville, United States. Operations in the medical devices sector involve the development, manufacturing, and sale of products such as intra-aortic balloon catheters and arthroscopy pumps. These items are supplied to hospitals and surgery centers for use in various procedures aimed at supporting patient care. Focus is placed on equipment reliability for healthcare settings.
- Headquarters Clarksville, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website tn-mi.com
- Social LinkedIn
- Acquired by Mundomedis (Dec 2021)
- Legal Name Tnmi Inc
- Investors
- Acquired byMundomedis
(Dec 2021)
Products & Services of TNMI
TNMI offers a comprehensive portfolio of products and services, including Insightra Ultra 7FR IAB Catheter Kit and SmartVision Arthroscopy Pump.
FDA-approved catheter kit for intra-aortic balloon procedures in cardiovascular care.
Advanced pump for arthroscopy surgeries to enhance visibility and adjust automatically.
Investors in TNMI
TNMI has secured backing from 1 investor. Prominent investors backing the company include Mundomedis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Mundomedis is engaged in medical device industry investments. | mundomedis.ae | Dubai, United Arab Emirates |
Investor details for TNMI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TNMI
1 people are tracked at TNMI (1 in leadership).
| Name | Role | Group |
|---|---|---|
Kai W Trompeter | CEO | Leadership |
Complete people profiles for TNMI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of TNMI
2 dated milestones of TNMI across 20 years, from founding to its latest funding, stage changes and deals.
- Founded TNMI is founded.
- Exit Acquired by Mundomedis.
Competitors of TNMI
TNMI has 3 listed competitors in our database, 3 of them funded. They include InterValve, Insightra and Hybernia Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| intervalveinc.com | 2008 | Minneapolis, United States | $11.13M | Aortic valvuloplasty balloons are developed for valve stenosis treatment. | ||
| insightra.com | 2001 | Irvine, United States | $19.96M | 8 | Intra-aortic balloon catheters are developed for cardiology surgeries. | |
| hyberniamedical.com | 2006 | Uniondale, United States | $3.71M | Solutions for acute ischemic stroke treatment are developed. |
Detailed competitors of TNMI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as TNMI (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tnmi
Complete news archive for TNMI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TNMI
TNMI was founded in 2001.
TNMI is headquartered in Clarksville, United States. It is registered at Clarksville, Tennessee, United States.
Kai W Trompeter is the CEO of TNMI, as recorded in our data.
TNMI was founded in 2001 and is headquartered in Clarksville, United States. Operations in the medical devices sector involve the development, manufacturing, and sale of products such as intra-aortic balloon catheters and arthroscopy pumps. These items are supplied to hospitals and surgery centers for use in various procedures aimed at supporting patient care. Focus is placed on equipment reliability for healthcare settings.
TNMI's top competitors include Insightra, InterValve and Hybernia Medical.
TNMI offers Insightra Ultra 7FR IAB Catheter Kit and SmartVision Arthroscopy Pump.
TNMI has 1 investor. Key investors include Mundomedis.
TNMI operates through Tnmi Inc.
Yes. TNMI was acquired by Mundomedis in December 2021.